CGL
LLY icon

Clarius Group LLC’s Eli Lilly LLY Stock Holding History

Clarius Group LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.59M Sell
5,202
-437
-8% -$418K 0.32% 40
2025
Q3 		$4.3M Sell
5,639
-3,308
-37% -$2.46M 0.25% 45
2025
Q2 		$6.97M Buy
8,947
+1,588
+22% +$1.23M 0.41% 34
2025
Q1 		$6.08M Sell
7,359
-561
-7% -$467K 0.38% 33
2024
Q4 		$6.11M Buy
7,920
+1,884
+31% +$1.56M 0.42% 33
2024
Q3 		$5.35M Sell
6,036
-116
-2% -$104K 0.38% 36
2024
Q2 		$5.57M Sell
6,152
-270
-4% -$216K 0.39% 34
2024
Q1 		$5M Sell
6,422
-988
-13% -$703K 0.35% 37
2023
Q4 		$4.32M Sell
7,410
-527
-7% -$308K 0.36% 39
2023
Q3 		$4.26M Sell
7,937
-1,665
-17% -$858K 0.41% 37
2023
Q2 		$4.5M Buy
9,602
+541
+6% +$227K 0.35% 40
2023
Q1 		$3.11M Sell
9,061
-825
-8% -$278K 0.26% 49
2022
Q4 		$3.62M Buy
9,886
+188
+2% +$66.7K 0.33% 46
2022
Q3 		$3.14M Buy
9,698
+406
+4% +$129K 0.31% 40
2022
Q2 		$3.01M Buy
9,292
+649
+8% +$195K 0.3% 42
2022
Q1 		$2.39M Hold
8,643
– – 0.19% 62
2021
Q4 		$2.39M Buy
8,643
+214
+3% +$54.2K 0.19% 62
2021
Q3 		$1.95M Buy
8,429
+261
+3% +$64.4K 0.17% 68
2021
Q2 		$1.88M Sell
8,168
-183
-2% -$36.8K 0.17% 72
2021
Q1 		$1.56M Buy
8,351
+917
+12% +$179K 0.15% 80
2020
Q4 		$1.25M Buy
7,434
+764
+11% +$114K 0.14% 83
2020
Q3 		$987K Sell
6,670
-508
-7% -$78.6K 0.13% 85
2020
Q2 		$1.18M Buy
7,178
+620
+9% +$95.2K 0.17% 69
2020
Q1 		$910K Buy
6,558
+575
+10% +$79K 0.17% 72
2019
Q4 		$844K Buy
5,983
+270
+5% +$31.3K 0.13% 88
2019
Q3 		$639K Sell
5,713
-327
-5% -$36.4K 0.12% 100
2019
Q2 		$669K Buy
6,040
+1,404
+30% +$165K 0.13% 88
2019
Q1 		$602K Buy
4,636
+2,319
+100% +$282K 0.15% 85
2018
Q4 		$268K Buy
+2,317
New +$259K 0.1% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Clarius Group LLC's LLY Position: Q4 2025 in Review

Clarius Group LLC reduced its Eli Lilly (LLY) stake by 7.7% in Q4 2025, selling an estimated $418K and leaving 5,202 shares worth $5.59M. The position accounts for 0.32% of the portfolio, ranked #40.

Clarius Group LLC first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. The position peaked at $6.97M in Q2 2025. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Clarius Group LLC held 5,202 shares of Eli Lilly worth $5.59M as of Q4 2025.
  • Clarius Group LLC sold 437 Eli Lilly shares in Q4 2025, an estimated $418K.
  • Eli Lilly made up 0.32% of Clarius Group LLC's portfolio in Q4 2025, its #40 holding.
  • Clarius Group LLC first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • Clarius Group LLC's Eli Lilly position peaked at $6.97M in Q2 2025.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.